We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.09%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$541B
AUM Growth
+$82.1B
Cap. Flow
+$80.6B
Cap. Flow %
14.9%
Top 10 Hldgs %
15.6%
Holding
10,816
New
1,380
Increased
6,046
Reduced
2,042
Closed
943

Sector Composition

Rank Sector Weight
1 Technology 18.49%
2 Financials 9.06%
3 Consumer Discretionary 7.01%
4 Healthcare 6.25%
5 Industrials 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NERV icon
9701
Minerva Neurosciences
NERV
$185M
$27 ﹤0.01%
12
-10,540
-100% -$24.9K
PBSE
9702
PGIM US Large-Cap Buffer 20 ETF - September
PBSE
$29.5M
$27 ﹤0.01%
+1
New +$26
FEMB icon
9703
First Trust Emerging Markets Local Currency Bond ETF
FEMB
$358M
$26 ﹤0.01%
1
GROY.WS icon
9704
Gold Royalty Corp Warrants
GROY.WS
$145M
$26 ﹤0.01%
100
-41
-29% -$13
MVFG icon
9705
Monarch Volume Factor Global Unconstrained Index ETF
MVFG
$178M
$26 ﹤0.01%
+1
New +$27
THIR
9706
THOR Index Rotation ETF
THIR
$200M
$26 ﹤0.01%
+1
New +$26
RMSG
9707
Real Messenger Corp
RMSG
$4.94M
$26 ﹤0.01%
+10
New +$21
ELCV
9708
Eventide High Dividend ETF
ELCV
$247M
$25 ﹤0.01%
+1
New +$26
APCXW
9709
DELISTED
AppTech Payments Corp Warrant
APCXW
$24 ﹤0.01%
+200
New +$40
ETHZW
9710
DELISTED
ETHZilla Corp Warrant
ETHZW
$24 ﹤0.01%
2,676
+2,511
+1,522% +$24
CRMLW icon
9711
Critical Metals Corp Warrants
CRMLW
$13.5M
$24 ﹤0.01%
+105
New +$27
EQLT
9712
iShares MSCI Emerging Markets Quality Factor ETF
EQLT
$11.9M
$24 ﹤0.01%
+1
New +$25
AAM.WS
9713
DELISTED
AA Mission Acquisition Corp Warrants
AAM.WS
$24 ﹤0.01%
+341
New +$20
OAKM
9714
Oakmark U.S. Large Cap ETF
OAKM
$1.13B
$24 ﹤0.01%
+1
New +$24
TCBPW
9715
DELISTED
TC BioPharm (Holdings) plc Warrants
TCBPW
$24 ﹤0.01%
2,400
+1,219
+103% +$21
OAKUU
9716
DELISTED
Oak Woods Acquisition Corp Unit
OAKUU
$23 ﹤0.01%
+2
New +$23
CAPTW
9717
DELISTED
Captivision Inc Warrant
CAPTW
$22 ﹤0.01%
+1,700
New +$39
DRIP icon
9718
Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X ETF
DRIP
$98.4M
0
EVAV
9719
DELISTED
Direxion Daily Electric and Autonomous Vehicles Bull 2X Shares
EVAV
$22 ﹤0.01%
1
ADNWW
9720
DELISTED
Advent Technologies Holdings Warrant
ADNWW
$21 ﹤0.01%
2,608
-47,398
-95% -$474
IMNN icon
9721
Imunon
IMNN
$6.68M
$21 ﹤0.01%
2
SWVLW icon
9722
Swvl Holdings Corp Warrant
SWVLW
$148K
$21 ﹤0.01%
+1,491
New +$25
ZAPPW
9723
DELISTED
Zapp Electric Vehicles Group Limited Warrant
ZAPPW
$21 ﹤0.01%
2,666
-38,179
-93% -$351
ENLV icon
9724
Enlivex Ltd
ENLV
$35.2M
$19 ﹤0.01%
1
-213
-100% -$4.14K
BIS icon
9725
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.32M
$18 ﹤0.01%
1

Similar funds

UBS Group's Q4 2024 Portfolio in Review

As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,380 new positions and adding to 6,046 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.

  • UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
  • UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
  • UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
  • UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
  • UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
  • UBS Group opened 1,380 new positions and closed 943 in Q4 2024.
  • UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.

Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.